Compare
Abbott Laboratories vs Medtronic (ABT vs MDT)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Abbott Laboratories (ABT) returned -11.7% and Medtronic (MDT) +12.6%; so far this year the figures are -12.3% and +6.0%.
Abbott Laboratories is the larger company by market value, about 1.5 times the size of Medtronic.
On trailing earnings, ABT trades at 40.9 times and MDT at 25.0 times.
Revenue grew +10.0% at ABT and +9.8% at MDT over the last year.
ABT yields 2.29%. MDT yields 2.81%.
Data as of the latest close. Not investment advice.
Relative performance
| ABT | MDT | |
|---|---|---|
| Price | $109.93 | $101.80 |
| 1-day | -3.23% | -2.90% |
| YTD | -12.26% | +5.98% |
| 1 year | -11.73% | +12.61% |
| 3 years | +15.70% | +43.68% |
| Market cap | $190.4B | $130.2B |
| P/E | 40.9 | 25.0 |
| P/S | 3.95 | 3.47 |
| P/B | 3.73 | 2.59 |
| Revenue growth | +10.00% | +9.80% |
| EPS growth | -66.20% | +12.10% |
| Gross margin % | 56.9 | 65.0 |
| Net margin % | 9.7 | 13.9 |
| ROE % | 9.2 | 10.4 |
| Debt / equity | 0.61 | 0.56 |
| FCF yield % | 3.5 | 4.7 |
| Dividend yield % | 2.29 | 2.81 |
| Beta | 0.06 | 0.14 |
| RSI (14) | 58.5 | 63.8 |
| Technical rating |